Chee Meng Ng, PhD, PharmD

1. Mechanism-Based Competitive Binding Model to Investigate the Effect of Neonatal Fc Receptor Binding Affinity on the Pharmacokinetic of Humanized Anti-VEGF Monoclonal IgG1 Antibody in Cynomolgus Monkey. Ng Chee Meng, Fielder P J, Jin J, Deng R. (2016). The AAPS journal, 18(4), 948-59.
2. Incorporation of FcRn-mediated disposition model to describe the population pharmacokinetics of therapeutic monoclonal IgG antibody in clinical patients. Ng Chee Meng. (2016). Biopharmaceutics & drug disposition, 37(2), 107-19.
3. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome. Ng Chee Meng, Dombrowsky E, Lin H, Erlich M E, Moody D E, Barrett J S, Kraft W K. (2015). Pharmacotherapy, 35(7), 670-80.
4. Semi-mechanistic Multiple-Analyte Pharmacokinetic Model for an Antibody-Drug-Conjugate in Cynomolgus Monkeys. Lu D, Jin J Y, Girish S, Agarwal P, Li D, Prabhu S, Dere R C, Saad O M, Nazzal D, Koppada N, Ramanujan S, Ng Chee Meng. (2015). Pharmaceutical research, 32(6), 1907-19.
5. Novel method to predict body weight in children based on age and morphological facial features. Huang Zhi, Barrett J S, Barrett K, Barrett R, Ng Chee Meng. (2015). Journal of clinical pharmacology, 55(4), 447-51.

Cancer Center Member

Programs

• Drug Discovery, Delivery and Translational Therapeutics

College & Department

• College of Pharmacy
• Department of Pharmaceutical Sciences